Insulin aspart, recombinant Subcutaneous and Lutetium lu 177 dotatate Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Lutetium lu 177 dotatate Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: lutetium lu 177 dotatate
Brand name: Lutathera
Synonyms: Lutetium Lu 177 dotatate, Lutetium Lu 177 Dotatate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Luvox
- Insulin aspart, recombinant Subcutaneous-Luvox CR
- Insulin aspart, recombinant Subcutaneous-Luxiq
- Insulin aspart, recombinant Subcutaneous-Lybrel
- Insulin aspart, recombinant Subcutaneous-Lyderm
- Insulin aspart, recombinant Subcutaneous-Lydia E. Pinkham
- Lutetium lu 177 dotatate Intravenous-Insulin degludec
- Lutetium lu 177 dotatate Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Lutetium lu 177 dotatate Intravenous-Insulin Degludec (U-100) Vials
- Lutetium lu 177 dotatate Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Lutetium lu 177 dotatate Intravenous-Insulin degludec and liraglutide
- Lutetium lu 177 dotatate Intravenous-Insulin degludec and liraglutide Subcutaneous